1. | blackopsstreet | |
2. | BUYtheWeak | |
3. | sueellen | |
4. | charmor126 | |
5. | clarkfan |
1. | blackopsstreet | |
2. | BUYtheWeak | |
3. | sueellen | |
4. | charmor126 | |
5. | clarkfan |
1. | sueellen 10/02/2017 Ignyta Announces New Data Highlighting Immuno-Oncological Efficacy of RXDX-106 at 2017 AACR Tumor Immunology and Immunotherapy Meeting |
2. | blackopsstreet 10/18/2017 They need to raise money for manufacturing in anticipation of approval 2018 |
3. | BUYtheWeak 10/03/2017 I predict a partnership agreement very soon. |
4. | charmor126 10/18/2017 Trump killed biotech today |
5. | clarkfan 10/18/2017 Upped price target from 15 to 23 |